Gadolinium Mri

Gadolinium MRI and risk factors for the debilitatingthe patient's internal organs, tissues, bones and
disease nephrogenic systemic fibrosis (NSF) arevessels. MRI with gadolinium is used because it
currently being investigated by the Food and Drugprovides additional diagnostic information
Administration (FDA). An MRI with gadolinium is acompared to an MRI without contrast. The
type of MRI that uses a contrast agent withGadolinium for MRI agent is also referred to as
special magnetic properties to help increase thegadolinium-based contrast agents (GBCA). Five
visibility of organs and tissues. Since its approval inGBCAs are approved for magnetic resonance
1988, MRI with gadolinium has been administeredimaging in the United States: Magnevist,
to millions of patients.MultiHance, Omniscan, OptiMARK, and ProHance.
Magnetic resonance imaging (MRI) is a diagnosticEvidence has been increasing regarding the risk of
study that has been used since the 1980's. Annephrogenic systemic fibrosis (NSF) in patients
MRI uses strong magnets and radio waves towith severe kidney problems who receive
create computer generated three-dimensionalgadolinium during an MRI procedure. Nephrogenic
images of the body. When an MRI study issystemic fibrosis appears to occur in patients with
performed, radio waves are pulsed through thekidney failure. Patients with kidney disease or on
patient's body causing movement in hydrogenkidney dialysis are at increased risk because
atoms in the body's cells. Different parts of thegadolinium is primarily eliminated by the body
body react to the radio waves with predictablethrough the kidneys.
patterns. These patterns are displayed asRecent studies have shown an association
three-dimensional pictures on a computer screen.between NSF and patients with kidney disease
A gadolinium MRI is a special type of study wherethat have a gadolinium MRI. Unfortunately, there
the patient is injected with gadolinium. For MRIhas been little research or clinical trials that have
studies using gadolinium the procedure usuallystudied patients with kidney problems and
involves two MRIs. The first MRI is administeredgadolinium contrast agents. NSF causes fibrosis of
to get a baseline study. The second studythe skin and connective tissues throughout the
involves injecting the patient with gadolinium andbody. The patient's skin thickens leading to a loss
then taking a second MRI. Gadolinium is a naturallyof mobility and in some cases causing death.
occurring metallic element that has specialThere is no known treatment or cure for NSF.
magnetic properties. Gadolinium gives the treatingNSF has only been reported in patients with
physician and radiologist a more detailed picture ofsevere renal dysfunction (kidney disease).